Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Dec;102(Suppl 10):137–147. doi: 10.1289/ehp.94102s10137

Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms.

S N Giri 1, R Blaisdell 1, R B Rucker 1, Q Wang 1, D M Hyde 1
PMCID: PMC1567008  PMID: 7535685

Abstract

Interstitial pulmonary fibrosis induced by intratracheal instillation of bleomycin (BL) involves an excess production of reactive oxygen species, unavailability of adequate levels of NAD and ATP to repair the injured pulmonary epithelium, and an overexuberant lung collagen reactivity followed by deposition of highly cross-linked mature collagen fibrils resistant to enzymatic degradation. In the present study, we have demonstrated that dietary supplementation with taurine and niacin offered almost complete protection against the lung fibrosis in a multidose BL hamster model. The mechanisms for the protective effect of taurine and niacin are multifaceted. These include the ability of taurine to scavenge HOCl and stabilize the biomembrane; niacin's ability to replenish the BL-induced depletion of NAD and ATP; and the combined effect of taurine and niacin to suppress all aspects of BL-induced increases in the lung collagen reactivity, a hallmark of interstitial pulmonary fibrosis. It was concluded from the data presented at this Conference that the combined treatment with taurine and niacin, which offers a multipronged approach, will have great therapeutic potential in the intervention of the development of chemically induced interstitial lung fibrosis in animals and humans.

Full text

PDF
137

Images in this article

142Figure 4. A
on p.142
142Figure 4. B
on p.142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma J., Hamaguchi T., Ohta H., Takihara K., Awata N., Sawamura A., Harada H., Tanaka Y., Kishimoto S. Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: possible role of taurine in its prevention. Adv Exp Med Biol. 1987;217:167–179. doi: 10.1007/978-1-4899-0405-8_18. [DOI] [PubMed] [Google Scholar]
  2. Brown O. R., Heitkamp M., Song C. S. Niacin Reduces Paraquat Toxicity in Rats. Science. 1981 Jun 26;212(4502):1510–1512. doi: 10.1126/science.7233236. [DOI] [PubMed] [Google Scholar]
  3. Caspary W. J., Lanzo D. A., Niziak C. Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron. Biochemistry. 1982 Jan 19;21(2):334–338. doi: 10.1021/bi00531a021. [DOI] [PubMed] [Google Scholar]
  4. Chandler D. B., Hyde D. M., Giri S. N. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol. 1983 Aug;112(2):170–177. [PMC free article] [PubMed] [Google Scholar]
  5. Chien K. R., Abrams J., Serroni A., Martin J. T., Farber J. L. Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. J Biol Chem. 1978 Jul 10;253(13):4809–4817. [PubMed] [Google Scholar]
  6. Christner P., Fein A., Goldberg S., Lippmann M., Abrams W., Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1985 May;131(5):690–695. doi: 10.1164/arrd.1985.131.5.690. [DOI] [PubMed] [Google Scholar]
  7. Clark J. G., Overton J. E., Marino B. A., Uitto J., Starcher B. C. Collagen biosynthesis in bleomycin-induced pulmonary fibrosis in hamsters. J Lab Clin Med. 1980 Dec;96(6):943–953. [PubMed] [Google Scholar]
  8. Counts D. F., Evans J. N., Dipetrillo T. A., Sterling K. M., Jr, Kelley J. Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J Pharmacol Exp Ther. 1981 Dec;219(3):675–678. [PubMed] [Google Scholar]
  9. Crooke S. T., Bradner W. T. Bleomycin, a review. J Med. 1976;7(5):333–428. [PubMed] [Google Scholar]
  10. Eyre D. R., Koob T. J., Van Ness K. P. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 1984 Mar;137(2):380–388. doi: 10.1016/0003-2697(84)90101-5. [DOI] [PubMed] [Google Scholar]
  11. Fujimoto D., Moriguchi T. Pyridinoline, a non-reducible crosslink of collagen. Quantitative determination, distribution, and isolation of a crosslinked peptide. J Biochem. 1978 Mar;83(3):863–867. doi: 10.1093/oxfordjournals.jbchem.a131983. [DOI] [PubMed] [Google Scholar]
  12. Fukae M., Mechanic G. L. Maturation of collagenous tissue. Temporal sequence of formation of peptidyl lysine-derived cross-linking aldehydes and cross-links in collagen. J Biol Chem. 1980 Jul 10;255(13):6511–6518. [PubMed] [Google Scholar]
  13. Gadek J. E., Kelman J. A., Fells G., Weinberger S. E., Horwitz A. L., Reynolds H. Y., Fulmer J. D., Crystal R. G. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med. 1979 Oct 4;301(14):737–742. doi: 10.1056/NEJM197910043011401. [DOI] [PubMed] [Google Scholar]
  14. Gallop P. M., Blumenfeld O. O., Henson E., Schneider A. L. Isolation and identification of alpha-amino aldehydes in collagen. Biochemistry. 1968 Jun;7(6):2409–2430. doi: 10.1021/bi00846a051. [DOI] [PubMed] [Google Scholar]
  15. Garnick M. B. Advanced testicular cancer: treatment choices in the "land of plenty". J Clin Oncol. 1985 Mar;3(3):294–297. doi: 10.1200/JCO.1985.3.3.294. [DOI] [PubMed] [Google Scholar]
  16. Giri S. N., Chen Z. L., Younker W. R., Schiedt M. J. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters. Toxicol Appl Pharmacol. 1983 Oct;71(1):132–141. doi: 10.1016/0041-008x(83)90052-2. [DOI] [PubMed] [Google Scholar]
  17. Giri S. N., Hyde D. M., Nakashima J. M. Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters. Toxicol Pathol. 1986;14(2):149–157. doi: 10.1177/019262338601400202. [DOI] [PubMed] [Google Scholar]
  18. Giri S. N., Misra H. P., Chandler D. B., Chen Z. L. Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters. Exp Mol Pathol. 1983 Dec;39(3):317–326. doi: 10.1016/0014-4800(83)90060-6. [DOI] [PubMed] [Google Scholar]
  19. Giri S. N., Nakashima J. M., Curry D. L. Effects of intratracheal administration of bleomycin or saline in pair-fed and control-fed hamsters on daily food intake and on plasma levels of glucose, cortisol, and insulin, and lung levels of calmodulin, calcium, and collagen. Exp Mol Pathol. 1985 Apr;42(2):206–219. doi: 10.1016/0014-4800(85)90028-0. [DOI] [PubMed] [Google Scholar]
  20. Gordon R. E., Heller R. F., Del Valle J. R., Heller R. F. Membrane perturbations and mediation of gap junction formation in response to taurine treatment in normal and injured alveolar epithelia. Exp Lung Res. 1989 Dec;15(6):895–908. doi: 10.3109/01902148909069634. [DOI] [PubMed] [Google Scholar]
  21. Haschek W. M., Witschi H. Pulmonary fibrosis--a possible mechanism. Toxicol Appl Pharmacol. 1979 Dec;51(3):475–487. doi: 10.1016/0041-008x(79)90372-7. [DOI] [PubMed] [Google Scholar]
  22. Horwitz A. L., Hance A. J., Crystal R. G. Granulocyte collagenase: selective digestion of type I relative to type III collagen. Proc Natl Acad Sci U S A. 1977 Mar;74(3):897–901. doi: 10.1073/pnas.74.3.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hussain M. Z., Giri S. N., Bhatnagar R. S. Poly(ADP-ribose) synthetase activity during bleomycin-induced lung fibrosis in hamsters. Exp Mol Pathol. 1985 Oct;43(2):162–176. doi: 10.1016/0014-4800(85)90037-1. [DOI] [PubMed] [Google Scholar]
  24. Huxtable R. J. From heart to hypothesis: a mechanism for the calcium modulatory actions of taurine. Adv Exp Med Biol. 1987;217:371–387. doi: 10.1007/978-1-4899-0405-8_39. [DOI] [PubMed] [Google Scholar]
  25. Hyde D. M., Giri S. N. Polyinosinic-polycytidylic acid, an interferon inducer, ameliorates bleomycin-induced lung fibrosis in mice. Exp Lung Res. 1990 Sep-Oct;16(5):533–546. doi: 10.3109/01902149009068825. [DOI] [PubMed] [Google Scholar]
  26. James J., Bosch K. S., Zuyderhoudt F. M., Houtkooper J. M., van Gool J. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry. 1986;85(2):129–133. doi: 10.1007/BF00491759. [DOI] [PubMed] [Google Scholar]
  27. Karlinsky J. B., Goldstein R. H. Fibrotic lung disease--a perspective. J Lab Clin Med. 1980 Dec;96(6):939–942. [PubMed] [Google Scholar]
  28. Kelley J., Newman R. A., Evans J. N. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis. J Lab Clin Med. 1980 Dec;96(6):954–964. [PubMed] [Google Scholar]
  29. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  30. Last J. A., Reiser K. M. Biosynthesis of collagen crosslinks. III. In vivo labeling and stability of lung collagen in rats with bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1989 Aug;1(2):111–117. doi: 10.1165/ajrcmb/1.2.111. [DOI] [PubMed] [Google Scholar]
  31. Last J. A., Summers P., Reiser K. M. Biosynthesis of collagen crosslinks. II. In vivo labelling and stability of lung collagen in rats. Biochim Biophys Acta. 1989 Feb 24;990(2):182–189. doi: 10.1016/s0304-4165(89)80032-7. [DOI] [PubMed] [Google Scholar]
  32. Laurent G. J., McAnulty R. J. Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen. Am Rev Respir Dis. 1983 Jul;128(1):82–88. doi: 10.1164/arrd.1983.128.1.82. [DOI] [PubMed] [Google Scholar]
  33. Ledson M. J., Bucknall R. C., Edwards S. W. Inhibition of neutrophil oxidant secretion by D-penicillamine: scavenging of H2O2 and HOCl. Ann Rheum Dis. 1992 Mar;51(3):321–325. doi: 10.1136/ard.51.3.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Malone J. D., Richards M., Jeffrey J. J. Recruitment of peripheral mononuclear cells by mammalian collagenase digests of type I collagen. Matrix. 1991 Aug;11(4):289–295. doi: 10.1016/s0934-8832(11)80237-4. [DOI] [PubMed] [Google Scholar]
  35. Marom Z., Weinberg K. S., Fanburg B. L. Effect of bleomycin on collagenolytic activity of the rat alveolar macrophage. Am Rev Respir Dis. 1980 May;121(5):859–867. doi: 10.1164/arrd.1980.121.5.859. [DOI] [PubMed] [Google Scholar]
  36. McLoughlin D. M., Stapleton P. P., Bloomfield F. J. Influence of taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response. Biochem Soc Trans. 1991 Feb;19(1):73–78. doi: 10.1042/bst0190073. [DOI] [PubMed] [Google Scholar]
  37. McQuaid A., Lamand M., Mason J. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy. J Lab Clin Med. 1992 Jun;119(6):744–750. [PubMed] [Google Scholar]
  38. Miller R. L., Udenfriend S. Hydroxylation of proline residues in collagen nascent chains. Arch Biochem Biophys. 1970 Jul;139(1):104–113. doi: 10.1016/0003-9861(70)90051-2. [DOI] [PubMed] [Google Scholar]
  39. Montaño M., Ramos C., González G., Vadillo F., Pardo A., Selman M. Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest. 1989 Nov;96(5):1115–1119. doi: 10.1378/chest.96.5.1115. [DOI] [PubMed] [Google Scholar]
  40. Nakamori K., Koyama I., Nakamura T., Yoshida T., Umeda M., Inoue K. Effectiveness of taurine in protecting biomembrane against oxidant. Chem Pharm Bull (Tokyo) 1990 Nov;38(11):3116–3119. doi: 10.1248/cpb.38.3116. [DOI] [PubMed] [Google Scholar]
  41. Nakashima J. M., Levin J. R., Hyde D. M., Giri S. N. Repeated exposures to enzyme-generated oxidants cause alveolitis, epithelial hyperplasia, and fibrosis in hamsters. Am J Pathol. 1991 Dec;139(6):1485–1499. [PMC free article] [PubMed] [Google Scholar]
  42. Nakashima T., Takino T., Kuriyama K. Therapeutic and prophylactic effects of taurine administration on experimental liver injury. Prog Clin Biol Res. 1983;125:449–459. [PubMed] [Google Scholar]
  43. Nimni M. E., Deshmukh K., Gerth N. Collagen defect induced by penicillamine. Nat New Biol. 1972 Dec 13;240(102):220–221. doi: 10.1038/newbio240220a0. [DOI] [PubMed] [Google Scholar]
  44. O'Neill C. A., Giri S. N. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP. Exp Lung Res. 1994 Jan-Feb;20(1):41–56. doi: 10.3109/01902149409064372. [DOI] [PubMed] [Google Scholar]
  45. O'Neill C. A., Giri S. N., Wang Q., Perricone M. A., Hyde D. M. Effects of dibutyrylcyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters. J Appl Toxicol. 1992 Apr;12(2):97–111. doi: 10.1002/jat.2550120206. [DOI] [PubMed] [Google Scholar]
  46. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 Jun;95(2):351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  47. Phan S. H., Thrall R. S., Williams C. Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism. Am Rev Respir Dis. 1981 Oct;124(4):428–434. doi: 10.1164/arrd.1981.124.4.428. [DOI] [PubMed] [Google Scholar]
  48. Pinnell S. R., Martin G. R. The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone. Proc Natl Acad Sci U S A. 1968 Oct;61(2):708–716. doi: 10.1073/pnas.61.2.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Postlethwaite A. E., Seyer J. M., Kang A. H. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A. 1978 Feb;75(2):871–875. doi: 10.1073/pnas.75.2.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Reiser K. M., Hennessy S. M., Last J. A. Analysis of age-associated changes in collagen crosslinking in the skin and lung in monkeys and rats. Biochim Biophys Acta. 1987 Dec 7;926(3):339–348. doi: 10.1016/0304-4165(87)90220-0. [DOI] [PubMed] [Google Scholar]
  51. Reiser K. M., Tryka A. F., Lindenschmidt R. C., Last J. A., Witschi H. R. Changes in collagen cross-linking in bleomycin-induced pulmonary fibrosis. J Biochem Toxicol. 1986 Mar;1(1):83–91. doi: 10.1002/jbt.2570010109. [DOI] [PubMed] [Google Scholar]
  52. Riley D. J., Kerr J. S., Berg R. A., Ianni B. D., Pietra G. G., Edelman N. H., Prockop D. J. beta-Aminopropionitrile prevents bleomycin-induced pulmonary fibrosis in the hamster. Am Rev Respir Dis. 1982 Jan;125(1):67–73. doi: 10.1164/arrd.1982.125.1.67. [DOI] [PubMed] [Google Scholar]
  53. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie. 1970 Jun;26(1):57–60. [PubMed] [Google Scholar]
  54. Selman M., Montaño M., Ramos C., Chapela R. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax. 1986 May;41(5):355–359. doi: 10.1136/thx.41.5.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Seyer J. M., Hutcheson E. T., Kang A. H. Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest. 1976 Jun;57(6):1498–1507. doi: 10.1172/JCI108420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Siegel R. C. Lysyl oxidase. Int Rev Connect Tissue Res. 1979;8:73–118. doi: 10.1016/b978-0-12-363708-6.50009-6. [DOI] [PubMed] [Google Scholar]
  57. Snider G. L., Hayes J. A., Korthy A. L. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am Rev Respir Dis. 1978 Jun;117(6):1099–1108. doi: 10.1164/arrd.1978.117.6.1099. [DOI] [PubMed] [Google Scholar]
  58. Stubberfield C. R., Cohen G. M. NAD+ depletion and cytotoxicity in isolated hepatocytes. Biochem Pharmacol. 1988 Oct 15;37(20):3967–3974. doi: 10.1016/0006-2952(88)90081-0. [DOI] [PubMed] [Google Scholar]
  59. Sugiura Y., Kikuchi T. Formation of superoxide and hydroxy radicals in iron(II)-bleomycin-oxygen system: electron spin resonance detection by spin trapping. J Antibiot (Tokyo) 1978 Dec;31(12):1310–1312. doi: 10.7164/antibiotics.31.1310. [DOI] [PubMed] [Google Scholar]
  60. Thrall R. S., McCormick J. R., Jack R. M., McReynolds R. A., Ward P. A. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol. 1979 Apr;95(1):117–130. [PMC free article] [PubMed] [Google Scholar]
  61. Trush M. A., Mimnaugh E. G., Ginsburg E., Gram T. E. Studies on the interaction of bleomycin A2 with rat lung microsomes. II. Involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage. J Pharmacol Exp Ther. 1982 Apr;221(1):159–165. [PubMed] [Google Scholar]
  62. WOESSNER J. F., Jr The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961 May;93:440–447. doi: 10.1016/0003-9861(61)90291-0. [DOI] [PubMed] [Google Scholar]
  63. Wang Q. J., Giri S. N., Hyde D. M., Nakashima J. M., Javadi I. Niacin attenuates bleomycin-induced lung fibrosis in the hamster. J Biochem Toxicol. 1990 Spring;5(1):13–22. doi: 10.1002/jbt.2570050104. [DOI] [PubMed] [Google Scholar]
  64. Wang Q., Giri S. N., Hyde D. M. Characterization of a phospholipase A2 in hamster lung and in vitro and in vivo effects of bleomycin on this enzyme. Prostaglandins Leukot Essent Fatty Acids. 1989 May;36(2):85–92. doi: 10.1016/0952-3278(89)90023-9. [DOI] [PubMed] [Google Scholar]
  65. Wang Q., Hyde D. M., Giri S. N. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin. Lab Invest. 1992 Aug;67(2):234–242. [PubMed] [Google Scholar]
  66. Weitberg A. B. Effect of nicotinic acid supplementation in vivo on oxygen radical-induced genetic damage in human lymphocytes. Mutat Res. 1989 Aug;216(4):197–201. doi: 10.1016/0165-1161(89)90005-8. [DOI] [PubMed] [Google Scholar]
  67. Willcox M., Kervitsky A., Watters L. C., King T. E., Jr Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method. Am Rev Respir Dis. 1988 Jul;138(1):74–80. doi: 10.1164/ajrccm/138.1.74. [DOI] [PubMed] [Google Scholar]
  68. Witschi H. R., Haschek W. M., Klein-Szanto A. J., Hakkinen P. J. Potentiation of diffuse lung damage by oxygen: determining variables. Am Rev Respir Dis. 1981 Jan;123(1):98–103. doi: 10.1164/arrd.1981.123.1.98. [DOI] [PubMed] [Google Scholar]
  69. Witschi H., Godfrey G., Frome E., Lindenschmidt R. C. Pulmonary toxicity of cytostatic drugs: cell kinetics. Fundam Appl Toxicol. 1987 Feb;8(2):253–262. doi: 10.1016/0272-0590(87)90124-2. [DOI] [PubMed] [Google Scholar]
  70. Wright C. E., Tallan H. H., Lin Y. Y., Gaull G. E. Taurine: biological update. Annu Rev Biochem. 1986;55:427–453. doi: 10.1146/annurev.bi.55.070186.002235. [DOI] [PubMed] [Google Scholar]
  71. Zia S., Hyde D. M., Giri S. N. Development of a bleomycin hamster model of subchronic lung fibrosis. Pathology. 1992 Jul;24(3):155–163. doi: 10.3109/00313029209063164. [DOI] [PubMed] [Google Scholar]
  72. Zuckerman J. E., Hollinger M. A., Giri S. N. Evaluation of antifibrotic drugs in bleomycin-induced pulmonary fibrosis in hamsters. J Pharmacol Exp Ther. 1980 Jun;213(3):425–431. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES